{"id":1176,"date":"2019-08-30T14:21:32","date_gmt":"2019-08-30T12:21:32","guid":{"rendered":"http:\/\/haavind.local\/en\/2019\/08\/30\/pharma-report-summer-2019\/"},"modified":"2022-07-21T12:51:12","modified_gmt":"2022-07-21T12:51:12","slug":"pharma-report-summer-2019","status":"publish","type":"post","link":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/","title":{"rendered":"The Haavind Pharma Report Summer 2019"},"content":{"rendered":"\t<div class=\"template-post alignwide wp-block-dekode-hero\">\n\t\t<div class=\"hero__inner\">\n\t\t\t<div class=\"hero__inner_blocks\">\n\t\t\t\t<h1 class=\"wp-block-post-title\">The Haavind Pharma Report Summer 2019<\/h1>\n\n<p>In the Pharma Report Summer 2019, we take a retrospective look at some of the legal developments during the first half of 2019 in the Norwegian pharmaceutical sector.<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div><\/div>\n\t\t\t\t\t<div class=\"post-meta\">\n\t\t\t\t\t\t<span class=\"info-small\">30 August, 2019 \u00b7 2 min. reading time<\/span>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\n<div class=\"alignleft wp-block-haavind-byline\">\n\t\t\t\t<span class=\"author-tag\">Written by<\/span>\n\t\t\t\t<div class=\"authors\"><a href=\"https:\/\/haavind.stage01.dekodes.no\/en\/people\/hakon-austdal\/\" class=\"t2-byline__author-link\">\n\t\t\t\t\t<div class=\"author-inner\">\n\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2016\/04\/Ha\u030akon-Austdal-233x300.jpg\" \/>\n\t\t\t\t\t\t<div>\n\t\t\t\t\t\t<span class=\"name\">H\u00e5kon Austdal<\/span>\n\t\t\t\t\t\t<span>Specialist Counsel<\/span>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/a><a href=\"https:\/\/haavind.stage01.dekodes.no\/en\/people\/vebjorn-krag-iversen\/\" class=\"t2-byline__author-link\">\n\t\t\t\t\t<div class=\"author-inner\">\n\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2016\/04\/Vebjorn-Iversen-233x300.jpg\" \/>\n\t\t\t\t\t\t<div>\n\t\t\t\t\t\t<span class=\"name\">Vebj\u00f8rn Krag Iversen<\/span>\n\t\t\t\t\t\t<span>Partner<\/span>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/a><\/div>\n\t\t\t\t<div class=\"topics\">\n\t\t\t\t<span>Topics<\/span>\n\t\t\t\t<div><a class=\"tag-link\" href=\"https:\/\/haavind.stage01.dekodes.no\/en\/expertise\/dispute-resolution\">Dispute resolution<\/a><span class=\"tag-link\">Intellectual property rights<\/span><span class=\"tag-link\">Healthcare and life science<\/span><\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\n<p>In the Pharma Report Summer 2019, we take a retrospective look at some of the legal developments during the first half of 2019 in the Norwegian pharmaceutical sector.<\/p>\n\n\n<p>The first half of 2019 has been an interesting year for legal practitioners working in the pharmaceutical sector. While there has been less litigation so far, the first 6 months has nevertheless been interesting, particularly from a regulatory viewpoint.<a href=\"https:\/\/indd.adobe.com\/view\/b944e36b-2ebd-4842-b13d-22e6056cc7ec\"><strong>Read the Pharma Report Summer 2019 here<\/strong><\/a><\/p>\n\n\n\n<p>In this edition of our biannual report, you can read about the latest developments on off-label use of medicinal products in Norway. You can also read about the latest amendments in patent legislation, which entered into force in July 2019, as well as the development concerning transparency on both prices of medicinal products and disclosure of payments to healthcare professionals.<a href=\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2019\/08\/Haavind-Pharma-Report-Summer-2019.pdf\"><strong>Download the Pharma Report Summer 2019 here<\/strong> <\/a><\/p>\n\n\n<div class=\"wp-block-image\"><figure class=\"alignleft\"><img loading=\"lazy\" decoding=\"async\" width=\"1000\" height=\"640\" src=\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/Haavind-Pharma-Report-Summer.jpg\" alt=\"Haavind Pharma Report Summer\" class=\"wp-image-1973\" title=\"Haavind Pharma Report Summer\" srcset=\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/Haavind-Pharma-Report-Summer.jpg 1000w, https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/Haavind-Pharma-Report-Summer-300x192.jpg 300w, https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/Haavind-Pharma-Report-Summer-768x492.jpg 768w\" sizes=\"(max-width: 1000px) 100vw, 1000px\" \/><figcaption>Haavind Pharma Report Summer<\/figcaption><\/figure><\/div>\n\n\n<p><em>Haavind\u2019s Health and Life Science team continuously and closely monitors developments in Norway relevant to the pharma sector. If you wish to discuss how your business can best meet the legal challenges of this innovative and highly regulated sector, you are always welcome to contact us.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In the Pharma Report Summer 2019, we take a retrospective look at some of the legal developments during the first half of 2019 in the Norwegian pharmaceutical sector.<\/p>\n","protected":false},"author":0,"featured_media":1973,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"sector":[7],"speciality":[17,24],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.2 (Yoast SEO v24.2) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The Haavind Pharma Report Summer 2019 - Haavind EN<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Haavind Pharma Report Summer 2019\" \/>\n<meta property=\"og:description\" content=\"In the Pharma Report Summer 2019, we take a retrospective look at some of the legal developments during the first half of 2019 in the Norwegian pharmaceutical sector.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/\" \/>\n<meta property=\"og:site_name\" content=\"Haavind EN\" \/>\n<meta property=\"article:published_time\" content=\"2019-08-30T12:21:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-21T12:51:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/Haavind-Pharma-Report-Summer.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/\",\"url\":\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/\",\"name\":\"The Haavind Pharma Report Summer 2019 - Haavind EN\",\"isPartOf\":{\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/Haavind-Pharma-Report-Summer.jpg\",\"datePublished\":\"2019-08-30T12:21:32+00:00\",\"dateModified\":\"2022-07-21T12:51:12+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/#primaryimage\",\"url\":\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/Haavind-Pharma-Report-Summer.jpg\",\"contentUrl\":\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/Haavind-Pharma-Report-Summer.jpg\",\"width\":1000,\"height\":640,\"caption\":\"Haavind Pharma Report Summer\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Dispute resolution\",\"item\":\"https:\/\/haavind.stage01.dekodes.no\/en\/kompetanse\/fagomrade\/dispute-resolution\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Haavind Pharma Report Summer 2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/#website\",\"url\":\"https:\/\/haavind.stage01.dekodes.no\/en\/\",\"name\":\"Haavind EN\",\"description\":\"-\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/haavind.stage01.dekodes.no\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"The Haavind Pharma Report Summer 2019 - Haavind EN","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/","og_locale":"en_US","og_type":"article","og_title":"The Haavind Pharma Report Summer 2019","og_description":"In the Pharma Report Summer 2019, we take a retrospective look at some of the legal developments during the first half of 2019 in the Norwegian pharmaceutical sector.","og_url":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/","og_site_name":"Haavind EN","article_published_time":"2019-08-30T12:21:32+00:00","article_modified_time":"2022-07-21T12:51:12+00:00","og_image":[{"width":1000,"height":640,"url":"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/Haavind-Pharma-Report-Summer.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/","url":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/","name":"The Haavind Pharma Report Summer 2019 - Haavind EN","isPartOf":{"@id":"https:\/\/haavind.stage01.dekodes.no\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/#primaryimage"},"image":{"@id":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/#primaryimage"},"thumbnailUrl":"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/Haavind-Pharma-Report-Summer.jpg","datePublished":"2019-08-30T12:21:32+00:00","dateModified":"2022-07-21T12:51:12+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/#primaryimage","url":"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/Haavind-Pharma-Report-Summer.jpg","contentUrl":"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/Haavind-Pharma-Report-Summer.jpg","width":1000,"height":640,"caption":"Haavind Pharma Report Summer"},{"@type":"BreadcrumbList","@id":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-summer-2019\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Dispute resolution","item":"https:\/\/haavind.stage01.dekodes.no\/en\/kompetanse\/fagomrade\/dispute-resolution\/"},{"@type":"ListItem","position":2,"name":"The Haavind Pharma Report Summer 2019"}]},{"@type":"WebSite","@id":"https:\/\/haavind.stage01.dekodes.no\/en\/#website","url":"https:\/\/haavind.stage01.dekodes.no\/en\/","name":"Haavind EN","description":"-","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/haavind.stage01.dekodes.no\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/posts\/1176"}],"collection":[{"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/comments?post=1176"}],"version-history":[{"count":1,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/posts\/1176\/revisions"}],"predecessor-version":[{"id":3729,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/posts\/1176\/revisions\/3729"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/media\/1973"}],"wp:attachment":[{"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/media?parent=1176"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/categories?post=1176"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/tags?post=1176"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/sector?post=1176"},{"taxonomy":"speciality","embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/speciality?post=1176"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}